Abstract
Newcastle disease virus (NDV) is used as an antineoplastic agent in clinical tumor therapy. It has prompted much interest as an anticancer agent because it can replicate up to 10,000 times better in human cancer cells than in most normal cells. This study was carried out to determine the oncolytic potential of NDV strain AF2240 and V4-UPM on WEHI-3B leukemia cell line. Results from MTT cytotoxicity assay showed that the CD50 values for both strains were 2 and 8 HAU for AF2240 and V4-UPM, respectively. In addition, bromodeoxyuridine (BrdU) and trypan blue dye exclusion assays showed inhibition in cell proliferation after different periods. Increase in the cellular level of caspase-3 and detection of DNA laddering using agarose gel electrophoresis on treated cells with NDV confirmed that the mode of cell death was apoptosis. In addition, flow-cytometry analysis of cellular DNA content showed that the virus caused an increase in the sub-G1 region (apoptosis peaks). In conclusion, NDV strains AF2240 and V4-UPM caused cytolytic effects against WEHI-3B leukemic cell line.
Highlights
Leukemia is a malignant neoplasm, characterized by neoplastic proliferation of hematopoietic cells, namely their diffuse replacement of the normal bone marrow [1,2]
There was a significant increase in apoptosis (Sub-G1) induction with time (p < 0.05) of WEHI-3B cell treated with both Newcastle disease virus (NDV) strains compared to untreated cells
In this study we reported that both NDV strains stimulate DNA fragmentation characteristic of apoptosis in WEHI-3B cell line at 24, 48 and 72 h post-inoculation
Summary
Leukemia is a malignant neoplasm, characterized by neoplastic proliferation of hematopoietic cells, namely their diffuse replacement of the normal bone marrow [1,2]. NDV is one of the nonengineered oncolytic viruses, which has a long history as a broad-spectrum oncolytic agent that can destroy tumor cells and stimulate the immune system [5]. It has oncolytic activity that can destroy tumor cells and stimulate the immune system. The oncolytic effects of six Malaysian strains of NDV (AF2240, 01/C, Ijuk, S, F, and V4) have been studied on several tumor cell lines [5,7]. No studies have yet been made using NDV oncolytic activity on myelomoncytic leukemia. In this study the oncolytic effects of two Malaysian local NDV strains AF2240 and V4-UPM were tested in vitro against Mouse myelomoncytic leukemia cell line, WEHI-3B
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
